# HALO (Halozyme Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Halozyme Therapeutics, Inc. reported $1.80B in revenue and net income of $485.4M for the trailing twelve months ended September 30, 2026 (up 39.2% year over year), with a 82.3% gross margin and a 37.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/HALO
- Markdown: https://convexityos.com/fundamentals/HALO.md
- SEC CIK: 0001159036
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001159036&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $1.80B | +39.2% YoY |
| Operating Income | TTM | $674.2M | 37.4% margin |
| Net Income | TTM | $485.4M | 26.9% net margin |
| Diluted EPS | TTM | $3.96 | Split-adjusted |
| Free Cash Flow | TTM | $885.9M | 49.1% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $1.03B | Total debt: $3.28B |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.40B | $1.02B | $829.3M | $660.1M | $443.3M | $267.6M | $196.0M | $151.9M | $316.6M | $146.7M |
| Cost of Revenue | $228.8M | $159.4M | $192.4M | $139.3M | $81.41M | $43.37M | $45.55M | $10.14M | $31.15M | $33.21M |
| **Gross Profit** | $1.17B | $855.9M | $636.9M | $520.8M | $361.9M | $224.2M | $150.4M | $141.7M | $285.5M | $113.5M |
| Research & Development | $81.49M | $79.05M | $76.36M | $66.61M | $35.67M | $34.24M | $140.8M | $150.3M | $150.6M | $150.8M |
| Selling, General & Admin | $207.1M | $154.3M | $149.2M | $143.5M | $50.32M | $45.74M | $77.25M | $60.80M | $53.82M | $45.85M |
| **Operating Income** | $469.0M | $551.5M | $337.6M | $267.5M | $275.9M | $144.3M | -$67.61M | -$69.33M | $81.00M | -$83.21M |
| **EBITDA** | $480.4M | $561.7M | $348.7M | $274.0M | $278.9M | $147.5M | -$63.54M | -$66.94M | $83.16M | -$80.80M |
| Interest Expense | $18.13M | $18.09M | $18.76M | $16.95M | $7.53M | $20.38M | $11.63M | $18.04M | $21.98M | $19.98M |
| Income Before Tax | $466.9M | $557.1M | $348.3M | $248.9M | $248.5M | $129.3M | -$72.25M | -$79.79M | $61.61M | -$101.9M |
| Income Tax Expense | $150.0M | $113.0M | $66.73M | $46.79M | -$154.2M | $217K | -$11K | $537K | -$1.36M | $1.16M |
| **Net Income** | $316.9M | $444.1M | $281.6M | $202.1M | $402.7M | $129.1M | -$72.24M | -$80.33M | $62.97M | -$103.0M |
| Basic EPS | $2.64 | $3.50 | $2.13 | $1.48 | $2.86 | $0.95 | -$0.50 | -$0.56 | $0.46 | -$0.81 |
| **Diluted EPS** | $2.56 | $3.43 | $2.10 | $1.44 | $2.74 | $0.91 | -$0.50 | -$0.56 | $0.45 | -$0.81 |
| Basic Shares Outstanding | 119.8M | 126.8M | 131.9M | 136.8M | 140.6M | 136.2M | 144.3M | 143.6M | 136.4M | 128.0M |
| Diluted Shares Outstanding | 123.9M | 129.4M | 134.2M | 140.6M | 146.8M | 141.5M | 144.3M | 143.6M | 139.1M | 128.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $493.0M | $481.0M | $376.7M | $451.8M | $354.3M | $325.7M | $264.9M | $298.0M |
| Cost of Revenue | $82.47M | $79.17M | $79.24M | $78.77M | $55.24M | $46.36M | $48.40M | $42.05M |
| **Gross Profit** | $410.5M | $401.8M | $297.5M | $373.0M | $299.0M | $279.4M | $216.5M | $256.0M |
| Research & Development | $27.78M | $27.66M | $25.56M | -- | $17.25M | $17.54M | $14.80M | $20.44M |
| Selling, General & Admin | $58.24M | $57.00M | $57.88M | $77.03M | $46.09M | $41.61M | $42.36M | $42.25M |
| **Operating Income** | $295.0M | $287.7M | $184.5M | -$92.89M | $217.9M | $202.4M | $141.5M | $175.5M |
| **EBITDA** | $299.7M | $292.2M | $188.7M | -$89.59M | $220.6M | $205.1M | $144.2M | $178.2M |
| Interest Expense | $6.04M | $5.59M | $5.51M | $4.91M | $4.30M | $4.39M | $4.53M | $4.54M |
| Income Before Tax | $290.6M | $284.9M | $180.3M | -$100.8M | $219.0M | $204.9M | $143.8M | $178.2M |
| Income Tax Expense | $43.58M | $54.99M | $30.28M | $40.74M | $43.73M | $39.78M | $25.73M | $41.20M |
| **Net Income** | $247.0M | $229.9M | $150.0M | -$141.6M | $175.2M | $165.2M | $118.1M | $137.0M |
| Basic EPS | $2.17 | $1.96 | $1.27 | -- | $1.49 | $1.36 | $0.96 | -- |
| **Diluted EPS** | $2.01 | $1.90 | $1.22 | -- | $1.43 | $1.33 | $0.93 | -- |
| Basic Shares Outstanding | 113.8M | 117.3M | 118.1M | -- | 117.2M | 121.3M | 123.2M | -- |
| Diluted Shares Outstanding | 122.6M | 121.2M | 122.9M | -- | 122.3M | 124.2M | 126.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $133.8M | $115.8M | $118.4M | $234.2M | $118.7M | $147.7M | $120.2M | $57.94M | $168.7M | $66.76M |
| Short-Term Investments | -- | -- | -- | $128.6M | $622.2M | $220.3M | $301.1M | -- | -- | -- |
| **Cash & Short-Term Investments** | $133.8M | $115.8M | $118.4M | $362.8M | $740.9M | $368.0M | $421.3M | $57.94M | $168.7M | $66.76M |
| Accounts Receivable, Net | $426.3M | $288.2M | $233.3M | $187.0M | $90.97M | $97.73M | $59.44M | $30.00M | $22.13M | $15.68M |
| Inventory | $176.5M | $141.9M | $127.6M | $100.1M | $53.91M | $60.75M | $29.36M | $22.62M | $5.15M | $14.62M |
| **Total Current Assets** | $825.2M | $1.09B | $746.4M | $739.0M | $926.3M | $554.8M | $543.4M | $427.8M | $510.4M | $256.5M |
| Property, Plant & Equipment, Net | $44.44M | $40.86M | $38.11M | $35.10M | $6.79M | $7.29M | $10.86M | $7.46M | $3.52M | $4.26M |
| Goodwill | $580.4M | $416.8M | $416.8M | $409.0M | $0 | -- | -- | -- | -- | -- |
| Intangible Assets | $981.5M | $401.8M | $472.9M | $546.7M | $0 | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $1.70B | $978.1M | $986.8M | $1.10B | $178.1M | $25.16M | $22.44M | $12.40M | $9.57M | $4.98M |
| **Total Assets** | $2.53B | $2.06B | $1.73B | $1.84B | $1.10B | $579.9M | $565.9M | $440.2M | $519.9M | $261.5M |
| Accounts Payable | $20.90M | $10.25M | $11.82M | $17.69M | $1.54M | $1.93M | $6.43M | $4.08M | $7.95M | $3.58M |
| Short-Term Debt | $0 | $0 | $0 | $13.33M | $89.42M | $397.2M | $19.54M | $91.51M | $77.21M | $17.39M |
| Deferred Revenue (Current) | -- | -- | -- | $3.25M | $1.75M | $1.75M | $4.01M | $4.25M | $6.57M | $4.79M |
| **Total Current Liabilities** | $177.1M | $139.1M | $112.5M | $130.8M | $117.1M | $421.4M | $85.64M | $149.4M | $131.3M | $54.59M |
| Long-Term Debt | $2.14B | $1.51B | $1.50B | $1.49B | $787.3M | $0 | $383.0M | $34.87M | $125.1M | $199.2M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $2.25M | $2.53M | $4.03M | $1.25M | $5.01M | $54.30M | $39.83M |
| Other Non-Current Liabilities | $113.9M | $54.76M | $37.72M | $32.69M | $544K | $3.47M | $4.18M | $2.12M | $814K | $358K |
| **Total Non-Current Liabilities** | $2.30B | $1.56B | $1.54B | $1.54B | $790.3M | $7.49M | $388.5M | $42.00M | $180.3M | $239.4M |
| **Total Liabilities** | $2.48B | $1.70B | $1.65B | $1.67B | $907.5M | $428.9M | $474.1M | $191.4M | $311.6M | $294.0M |
| **Total Debt (incl. Leases)** | $2.18B | $1.54B | $1.53B | $1.54B | $879.5M | $402.1M | $409.1M | $126.4M | $202.4M | $216.6M |
| Common Stock | $118K | $123K | $127K | $135K | $138K | $135K | $137K | $145K | $143K | $130K |
| Retained Earnings | $54.79M | $359.9M | $90.55M | $143.2M | -$58.91M | -$474.6M | -$603.7M | -$531.4M | -$522.4M | -$585.3M |
| Accumulated Other Comp. Income | -$18.09M | $3.83M | -$9.28M | -$922K | -$620K | $22K | $240K | -$277K | -$450K | -$6.0K |
| **Total Stockholders' Equity** | $48.81M | $363.8M | $83.81M | $169.8M | $197.0M | $151.0M | $91.77M | $248.9M | $208.4M | -$32.48M |
| Total Equity | $48.81M | $363.8M | $83.81M | $169.8M | $197.0M | $151.0M | $91.77M | $248.9M | $208.4M | -$32.48M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.03B | $163.1M | $309.7M | $133.8M | $419.7M | $61.86M | $176.3M | $115.8M |
| **Cash & Short-Term Investments** | $1.03B | $163.1M | $309.7M | $133.8M | $419.7M | $61.86M | $176.3M | $115.8M |
| Accounts Receivable, Net | $518.6M | $453.3M | $458.0M | $426.3M | $343.5M | $315.1M | $304.0M | $288.2M |
| Inventory | $132.6M | $137.1M | $155.5M | $176.5M | $185.8M | $181.5M | $164.9M | $141.9M |
| **Total Current Assets** | $1.85B | $933.0M | $1.00B | $825.2M | $1.33B | $1.12B | $1.26B | $1.09B |
| Property, Plant & Equipment, Net | $51.20M | $49.76M | $46.93M | $44.44M | $40.58M | $39.60M | $40.22M | $40.86M |
| Goodwill | $581.7M | $581.7M | $582.3M | $580.4M | $416.8M | $416.8M | $416.8M | $416.8M |
| Intangible Assets | $892.9M | $922.4M | $952.0M | $981.5M | $348.5M | $366.3M | $384.1M | $401.8M |
| **Total Non-Current Assets** | $1.63B | $1.64B | $1.67B | $1.70B | $892.5M | $931.2M | $934.5M | $978.1M |
| **Total Assets** | $3.47B | $2.58B | $2.67B | $2.53B | $2.22B | $2.05B | $2.20B | $2.06B |
| Accounts Payable | $33.55M | $23.61M | $14.10M | $20.90M | $15.36M | $18.69M | $20.07M | $10.25M |
| Short-Term Debt | $305.6M | $209.0M | $208.7M | $0 | $710.7M | -- | -- | $0 |
| **Total Current Liabilities** | $476.1M | $344.4M | $363.2M | $177.1M | $837.2M | $134.3M | $150.4M | $139.1M |
| Long-Term Debt | $2.94B | $1.94B | $1.94B | $2.14B | $800.1M | $1.51B | $1.51B | $1.51B |
| Other Non-Current Liabilities | $101.5M | $102.7M | $106.4M | $113.9M | $71.80M | $77.77M | $56.44M | $54.76M |
| **Total Non-Current Liabilities** | $3.05B | $2.09B | $2.09B | $2.30B | $880.1M | $1.59B | $1.56B | $1.56B |
| **Total Liabilities** | $3.53B | $2.43B | $2.45B | $2.48B | $1.72B | $1.72B | $1.71B | $1.70B |
| **Total Debt (incl. Leases)** | $3.28B | $2.18B | $2.18B | $2.18B | $1.54B | $1.54B | $1.54B | $1.54B |
| Common Stock | $114K | $114K | $118K | $118K | $118K | $118K | $123K | $123K |
| Retained Earnings | -$58.13M | $151.3M | $204.8M | $54.79M | $502.1M | $361.0M | $478.0M | $359.9M |
| Accumulated Other Comp. Income | $2.78M | -$7.83M | -$12.70M | -$18.09M | -$22.26M | -$28.40M | -$3.41M | $3.83M |
| **Total Stockholders' Equity** | -$55.24M | $143.5M | $219.6M | $48.81M | $503.9M | $332.7M | $482.3M | $363.8M |
| Total Equity | -$55.24M | $143.5M | $219.6M | $48.81M | $503.9M | $332.7M | $482.3M | $363.8M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $316.9M | $444.1M | $281.6M | $202.1M | $402.7M | $129.1M | -$72.24M | -$80.33M | $62.97M | -$103.0M |
| Depreciation & Amortization | $11.39M | $10.26M | $11.08M | $6.49M | $3.00M | $3.28M | $4.07M | $2.39M | $2.16M | $2.41M |
| Stock-Based Compensation | $51.56M | $43.38M | $36.62M | $24.40M | $20.82M | $17.20M | $34.78M | $35.70M | $30.67M | $25.59M |
| Change in Receivables | -$128.1M | -$74.25M | -$3.34M | -$83.94M | $6.75M | -$38.29M | -$29.44M | $11.61M | -$6.45M | $16.73M |
| Change in Inventory | $2.55M | -$67.38M | -$26.88M | -$17.48M | $7.37M | -$31.39M | -$6.73M | -$17.48M | $9.48M | -$5.13M |
| **Operating Cash Flow** | $651.6M | $479.1M | $388.6M | $240.1M | $299.4M | $55.45M | -$85.42M | -$49.50M | $134.1M | -$50.38M |
| Capital Expenditure | -$6.97M | -$10.70M | -$15.29M | -$4.81M | -$1.46M | -$2.50M | -$4.04M | -$4.66M | -$1.35M | -$3.14M |
| **Free Cash Flow** | $644.6M | $468.4M | $373.3M | $235.3M | $298.0M | $52.95M | -$89.46M | -$54.16M | $132.7M | -$53.52M |
| Acquisitions, Net | -$726.0M | $0 | $0 | -$999.1M | $0 | $0 | -- | -- | -- | -- |
| Purchases of Investments | -$247.4M | -$647.6M | -$292.9M | -$255.2M | -$652.5M | -$226.2M | -$389.8M | -$311.1M | -- | -- |
| **Investing Cash Flow** | -$545.8M | -$262.7M | -$96.91M | -$487.0M | -$406.3M | $78.35M | -$5.55M | $2.49M | -$163.7M | -$76.77M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | $0 | $0 | $134.9M | $0 |
| Share Repurchases | -$342.4M | -$250.0M | -$402.4M | -$200.0M | -$350.1M | -$150.1M | -$200.0M | $0 | $0 | -- |
| **Financing Cash Flow** | -$85.17M | -$218.9M | -$408.0M | $362.4M | $77.86M | -$106.3M | $153.2M | -$63.80M | $131.7M | $150.6M |
| **Net Change in Cash** | $20.57M | -$2.52M | -$116.3M | $115.5M | -$28.98M | $27.52M | $62.24M | -$110.8M | $102.0M | $23.47M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $247.0M | $229.9M | $150.0M | -$141.6M | $175.2M | $165.2M | $118.1M | $137.0M |
| Depreciation & Amortization | $4.70M | $4.50M | $4.22M | $3.30M | $2.70M | $2.70M | $2.69M | $2.65M |
| Stock-Based Compensation | $16.80M | $17.70M | $16.64M | $16.57M | $12.16M | $12.16M | $10.67M | $11.46M |
| Change in Receivables | -$69.77M | $2.16M | -$19.55M | -$90.48M | -$29.70M | -$11.72M | $3.83M | -$22.71M |
| Change in Inventory | $5.04M | $18.33M | $27.38M | $18.78M | -$1.10M | -$14.54M | -$586K | -$7.73M |
| **Operating Cash Flow** | $258.3M | $240.9M | $180.1M | $219.0M | $178.6M | $99.71M | $154.2M | $178.5M |
| Capital Expenditure | -$3.05M | -$4.17M | -$3.74M | -$1.43M | -$3.03M | -$1.56M | -$950K | -$3.05M |
| **Free Cash Flow** | $255.2M | $236.7M | $176.3M | $217.6M | $175.6M | $98.15M | $153.3M | $175.4M |
| Purchases of Investments | -$1.0K | -$111.8M | -$8.85M | $0 | -$4.96M | -$102.8M | -$139.6M | -$51.44M |
| **Investing Cash Flow** | $20.95M | -$62.66M | -$2.88M | -$741.8M | $201.6M | $84.79M | -$90.42M | $29.48M |
| Share Repurchases | -- | -- | -- | -- | -- | -- | -- | -$250.0M |
| **Financing Cash Flow** | $587.6M | -$326.3M | -$1.61M | $239.5M | -$22.40M | -$299.0M | -$3.32M | -$246.4M |
| **Net Change in Cash** | $866.9M | -$148.0M | $175.6M | -$283.2M | $357.8M | -$114.5M | $60.48M | -$38.47M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 83.6% | 84.3% | 76.8% | 78.9% | 81.6% | 83.8% | 76.8% | 93.3% | 90.2% | 77.4% |
| **Operating Margin** | 33.6% | 54.3% | 40.7% | 40.5% | 62.2% | 53.9% | -34.5% | -45.7% | 25.6% | -56.7% |
| **Net Profit Margin** | 22.7% | 43.7% | 34.0% | 30.6% | 90.8% | 48.2% | -36.9% | -52.9% | 19.9% | -70.2% |
| Return on Equity (ROE) | 649.2% | 122.1% | 336.0% | 119.0% | 204.5% | 85.5% | -78.7% | -32.3% | 30.2% | -- |
| Return on Assets (ROA) | 12.5% | 21.5% | 16.2% | 11.0% | 36.5% | 22.3% | -12.8% | -18.2% | 12.1% | -39.4% |
| Current Ratio | 4.66x | 7.80x | 6.64x | 5.65x | 7.91x | 1.32x | 6.35x | 2.86x | 3.89x | 4.70x |
| Quick Ratio | 3.66x | 6.78x | 5.50x | 4.88x | 7.45x | 1.17x | 6.00x | 2.71x | 3.85x | 4.43x |
| Debt to Equity | 44.60x | 4.22x | 18.27x | 9.07x | 4.47x | 2.66x | 4.46x | 0.51x | 0.97x | -- |
| **Revenue Growth (YoY)** | +37.6% | +22.4% | +25.6% | +48.9% | +65.7% | +36.5% | +29.1% | -52.0% | +115.8% | +8.6% |
| Gross Profit Growth (YoY) | +36.4% | +34.4% | +22.3% | +43.9% | +61.4% | +49.0% | +6.2% | -50.4% | +151.5% | +7.3% |
| Operating Income Growth (YoY) | -15.0% | +63.4% | +26.2% | -3.0% | +91.3% | -- | -- | -185.6% | -- | -- |
| **Net Income Growth (YoY)** | -28.6% | +57.7% | +39.3% | -49.8% | +212.0% | -- | -- | -227.6% | -- | -- |
| EPS Growth (YoY) | -24.6% | +64.3% | +43.9% | -48.3% | +201.1% | -- | -- | -221.7% | -- | -- |
| Operating Cash Flow Growth (YoY) | +36.0% | +23.3% | +61.8% | -19.8% | +440.0% | -- | -- | -136.9% | -- | -- |
| Free Cash Flow Growth (YoY) | +37.6% | +25.5% | +58.6% | -21.0% | +462.8% | -- | -- | -140.8% | -- | -- |
| 5Y Revenue / Share Growth | +493.2% | +489.5% | +494.4% | +107.8% | +175.0% | +84.3% | +121.2% | +117.7% | +509.1% | +109.6% |
| 10Y Revenue / Share Growth | +993.3% | +1203.8% | +1193.9% | +1166.0% | +476.4% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | +179.0% | -- | -- | +220.0% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 82.3% | 82.4% | 82.8% | 83.6% | 84.5% | 84.2% | 83.4% | 84.3% |
| **Operating Margin** | 37.4% | 35.9% | 33.9% | 33.6% | 59.3% | 57.9% | 55.1% | 54.3% |
| **Net Profit Margin** | 26.9% | 24.9% | 23.1% | 22.7% | 47.9% | 47.3% | 44.8% | 43.7% |
| Return on Equity (ROE) | -- | 288.1% | 158.8% | 649.2% | 118.2% | 167.5% | 100.6% | 122.1% |
| Return on Assets (ROA) | 14.0% | 16.0% | 13.1% | 12.5% | 26.8% | 27.1% | 22.1% | 21.5% |
| Current Ratio | 3.88x | 2.71x | 2.76x | 4.66x | 1.59x | 8.36x | 8.39x | 7.80x |
| Quick Ratio | 3.60x | 2.31x | 2.33x | 3.66x | 1.37x | 7.01x | 7.30x | 6.78x |
| Debt to Equity | -- | 15.18x | 9.91x | 44.60x | 3.05x | 4.62x | 3.19x | 4.22x |
| **Revenue Growth (YoY)** | +39.2% | +47.7% | +42.2% | +51.6% | +22.1% | +40.8% | +35.2% | +29.5% |
| Gross Profit Growth (YoY) | +37.3% | +43.8% | +37.4% | +45.7% | +24.3% | +45.7% | +29.2% | +44.0% |
| Operating Income Growth (YoY) | +35.4% | +42.1% | +30.4% | -152.9% | +33.5% | +72.7% | +48.1% | +73.7% |
| **Net Income Growth (YoY)** | +41.0% | +39.2% | +27.1% | -203.3% | +27.9% | +77.1% | +53.7% | +60.5% |
| EPS Growth (YoY) | +45.6% | +44.1% | +32.3% | -- | +38.0% | +86.3% | +57.4% | -- |
| Operating Cash Flow Growth (YoY) | +44.6% | +141.6% | +16.8% | +22.7% | +54.8% | +78.7% | +19.2% | +74.4% |
| Free Cash Flow Growth (YoY) | +45.4% | +141.2% | +15.0% | +24.0% | +54.2% | +84.4% | +21.8% | +75.8% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
